Seeking Alpha

Covidien's (COV) pharmaceuticals business, which it's spinning off under the name Mallinckrodt,...

Covidien's (COV) pharmaceuticals business, which it's spinning off under the name Mallinckrodt, will apply to list its shares on the NYSE and will trade with the ticker symbol MNK. Covidien expects to complete the process in the middle of the year. Mallinckrodt generated sales of $2B in 2012. (PR)
Comments (1)
  • JimConnors
    , contributor
    Comments (8) | Send Message
     
    What are the details of the spin-off? Will MNK be a leveraged buyout, or will existing COV shareholders get pro-rata shares in the new company?
    5 Feb 2013, 05:30 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|